Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection

NCT00352235 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: KRN7000

Sponsor

Foundation for Liver Research

Collaborators

[object Object]